Short Interest in Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Decreases By 16.5%

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) saw a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 30,900 shares, a decline of 16.5% from the February 13th total of 37,000 shares. Based on an average daily volume of 13,200 shares, the short-interest ratio is presently 2.3 days.

Algernon Pharmaceuticals Stock Performance

Algernon Pharmaceuticals stock opened at $0.06 on Thursday. The company’s 50-day moving average is $0.06 and its 200-day moving average is $0.06. Algernon Pharmaceuticals has a fifty-two week low of $0.04 and a fifty-two week high of $0.12.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.